Snowball logo
logo
RMD_logo

ResMed Inc

RMD โ€ข NYSE
$226.74+$0.74ย  (0.33%)
Estimate
P/E
23
EPS
9.86
Beta
0.748
Growth
Revenue, YoY
8.58%
Net income, YoY
0.98%
FCF, YoY
224.6%
Forecast
P/E (FWD)
18.8
EPS (FWD)
12.083
Dividends
Dividend yield
1.16%
Annual payout
$2.64
Next ex. div date
August 20, 26
Payout
40.19%
Div.growth, 5y
8.18%
Dividend growth streak
13 y
Div.rating
About the company
Ticker
RMD
ISIN
US7611521078
Country
United States of America
Sector (GICS)
Healthcare
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Frequently asked questions

What sector does ResMed Inc (RMD) operate in?

ResMed Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is ResMed Inc (RMD) current stock price?

As of the latest data, ResMed Inc stock price is $226.74, with a previous close of $226.00. ResMed Inc gained $0.74 in the last trading session, representing a 0.33% increase.

What is ResMed Inc (RMD) current market capitalization?

ResMed Inc market cap is approximately 32.89 billion.

What is ResMed Inc (RMD) Earnings Per Share (EPS)?

The trailing EPS is $9.86, and the forward EPS is $12.08.

What is ResMed Inc (RMD) Price-to-Earnings (P/E) ratio?

ResMed Inc current P/E ratio is 23, with a forward P/E of 18.77.

What is ResMed Inc (RMD) EBITDA?

ResMed Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 233.37 million.

Does ResMed Inc (RMD) pay dividends?

Yes. ResMed Inc pays quarterly dividends with an annualized yield of 1.16% and an estimated annual payout of $2.64 per share.

When is the next ex-dividend date for ResMed Inc (RMD)?

The next ex-dividend date is scheduled for August 20, 2026.

How did ResMed Inc (RMD) perform in its most recent earnings report?

In the last report (June 30, 2026), ResMed Inc posted an EPS surprise of 1.72% and a revenue surprise of -74.1%.

What is ResMed Inc (RMD) beta (volatility) score?

ResMed Inc has a beta of 0.748, indicating lower volatility than the overall market.